Optimal Protein Supplementation & Early Exercise In Mechanically

Status Recruiting

Clinical Trial Summary

A Pilot Randomized Controlled Trial (RCT) will be conducted where where mechanically ventilated patients will be randomized to optimal protein (Achieve 80% protein supplementation adequacy with daily titration) versus standard protein feeding. Both groups will receive standard usual early exercise therapy. Specific aim 1: To determine if optimal protein supplementation improves functional outcome of patients as measured by Functional Status Score (FSS) on Day 7. Specific aim 2: To determine if optimal protein supplementation reduces muscle loss of patients at Day 7 as measured by the Rectus Femoris thickness and cross-sectional area (RFCSA) using skeletal muscle ultrasound. Specific aim 3: To determine difference in functional recovery between groups using quality of life (QOL) scores and 6-minute walk distance at 3 months after hospital discharge. The hypothesis is protein inadequacy can be overcome with optimized protein supplementation to reduce muscle loss/sarcopenia and functional impairment in ICU survivors.

Clinical Trial Description

This study will be a prospective pilot randomized controlled trial. Collaboration will be between the National University Hospital (Medical, Surgical and Cardiothoracic ICUs), Centre for Healthy Aging, National University Health System (NUHS) and Physical Education & Sports Science, National Institute of Education (NIE). Patients admitted into these ICUs will be screened and those meeting the inclusion criteria will be approached for consent. If the patient is unable to consent, his/her legally acceptable representatives will be approached. This approach is routinely done in ICU studies. As with other ICU studies, potential difficulties in consenting and recruiting patients will be expected. To overcome this, all adult ICU patients at NUH will be included in the current study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05603585
Study type	Interventional
Source	National University Hospital, Singapore
Contact	Geetha Kayambu
Phone	6779 5555
Email	geetha_kayambu@nuhs.edu.sg
Status	Recruiting
Phase	N/A
Start date	September 6, 2022
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06206785` - Resting Energy Expenditure in Palliative Cancer Patients
Enrolling by invitation	`NCT05028192` - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Completed	`NCT01696604` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects	Phase 1
Recruiting	`NCT04627376` - Multimodal Program for Cancer Related Cachexia Prevention	N/A
Completed	`NCT02567773` - Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078	Phase 1
Completed	`NCT00866970` - Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia	Phase 2
Active, not recruiting	`NCT00710632` - Screening to Predict Weight Loss in Patients With Cancer	N/A
Completed	`NCT00031785` - Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer	Phase 3
Withdrawn	`NCT02017925` - Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation	N/A
Recruiting	`NCT01829880` - Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure	N/A
Completed	`NCT01419145` - A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study	N/A
Completed	`NCT01692990` - Study on the Effect of Fish Oil and Appetite	Phase 0
Terminated	`NCT00851448` - Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients	N/A
Completed	`NCT01015274` - Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Terminated	`NCT00962234` - Metabolism of Lipids in Advanced Cancer	N/A
Completed	`NCT00994669` - Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients	N/A
Completed	`NCT00972634` - Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer	N/A
Terminated	`NCT00535015` - Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer	Phase 2
Terminated	`NCT00558558` - Haelan and Nutrition in Cancer Patients	Phase 2
Withdrawn	`NCT00163072` - Pharmacokinetics and Safety of Transdermal Megestrol Acetate	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Optimal Protein Supplementation and Early Exercise In Mechanically Ventilated Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms